GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A

GMMA Group A Carbohydrate Group A Streptococcus glycoconjugate

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
28 Jun 2022
Historique:
received: 27 04 2022
revised: 20 06 2022
accepted: 23 06 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Group A

Identifiants

pubmed: 35891202
pii: vaccines10071034
doi: 10.3390/vaccines10071034
pmc: PMC9324507
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Engineering and Physical Sciences Research Council
ID : EP/R013764/1

Références

Clin Infect Dis. 2019 Aug 16;69(5):877-883
pubmed: 30624673
Int J Mol Sci. 2020 Nov 13;21(22):
pubmed: 33202815
J Exp Med. 1952 Dec;96(6):569-80
pubmed: 13022851
Front Immunol. 2013 Jan 10;3:406
pubmed: 23335921
Expert Rev Vaccines. 2013 Feb;12(2):183-98
pubmed: 23414409
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
pubmed: 10829079
Biomed Res Int. 2021 Mar 24;2021:1490732
pubmed: 33834062
Nat Rev Immunol. 2009 Apr;9(4):287-93
pubmed: 19247370
J Infect Dis. 2006 Jan 1;193(1):129-35
pubmed: 16323141
Vaccine. 2010 Aug 2;28(34):5513-23
pubmed: 20600514
Bioorg Chem. 2020 Jun;99:103815
pubmed: 32289587
Vaccine. 2011 Oct 26;29(46):8175-8
pubmed: 21920403
Immunity. 2007 Nov;27(5):687-90
pubmed: 18031690
Mol Cell Proteomics. 2012 Jun;11(6):M111.015693
pubmed: 22286755
Vaccines (Basel). 2020 Sep 17;8(3):
pubmed: 32957610
J Infect Dis. 1995 Mar;171(3):593-600
pubmed: 7876606
N Engl J Med. 2017 Aug 24;377(8):713-722
pubmed: 28834488
ACS Omega. 2017 Nov 30;2(11):8282-8289
pubmed: 30023580
Curr Top Microbiol Immunol. 2013;368:1-27
pubmed: 23242849
Immunopharmacol Immunotoxicol. 2016 Jun;38(3):184-96
pubmed: 27121368
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10428-10433
pubmed: 30262653
Vaccine. 2017 Jan 11;35(3):419-426
pubmed: 27998639
Nat Rev Microbiol. 2003 Dec;1(3):219-30
pubmed: 15035026
PLoS One. 2018 Jul 2;13(7):e0198658
pubmed: 29965967
Methods Mol Biol. 2021;2183:267-304
pubmed: 32959249
FEMS Microbiol Rev. 2018 May 1;42(3):388-423
pubmed: 29547971
Lancet. 2012 Mar 10;379(9819):953-964
pubmed: 22405798
Biotechnol J. 2019 Jul;14(7):1-2
pubmed: 31286673
J Bacteriol. 1988 Jun;170(6):2618-24
pubmed: 2453502
mSphere. 2019 Sep 25;4(5):
pubmed: 31554723
Lancet Infect Dis. 2009 Oct;9(10):611-6
pubmed: 19778763
Int J Mol Sci. 2020 Jun 21;21(12):
pubmed: 32575921
Methods Mol Biol. 2022;2414:227-279
pubmed: 34784041
Vaccines (Basel). 2021 Feb 09;9(2):
pubmed: 33572233
Cell Host Microbe. 2014 Jun 11;15(6):729-740
pubmed: 24922575
Front Immunol. 2021 Aug 03;12:715393
pubmed: 34413858
Front Immunol. 2021 Sep 14;12:719315
pubmed: 34594333
Eur Heart J. 2015 May 7;36(18):1115-22a
pubmed: 25425448
J Pharm Biomed Anal. 2000 Jan;21(6):1087-91
pubmed: 10708393
Nat Rev Immunol. 2013 Jul;13(7):475-86
pubmed: 23797063
J Infect Dis. 2014 Oct 15;210(8):1325-38
pubmed: 24799598
Sci Transl Med. 2018 Aug 29;10(456):
pubmed: 30158151
Carbohydr Res. 2014 Feb 19;385:1-8
pubmed: 24384528
Nat Rev Microbiol. 2021 May;19(5):287-302
pubmed: 33542518
Curr Opin Immunol. 2017 Apr;45:97-102
pubmed: 28319733
Bioanalysis. 2018 Mar 1;10(6):397-406
pubmed: 29451404
Semin Immunol. 2020 Aug;50:101433
pubmed: 33309166
Molecules. 2018 Jun 15;23(6):
pubmed: 29914046
ACS Infect Dis. 2020 Feb 14;6(2):281-290
pubmed: 31872763
Clin Microbiol Rev. 2000 Jul;13(3):470-511
pubmed: 10885988
Vaccine. 2010 Dec 10;29(1):104-14
pubmed: 20870056
Biotechnol J. 2017 Jul;12(7):
pubmed: 28397983
JAMA Pediatr. 2014 Nov;168(11):1073-4
pubmed: 25264869
Circulation. 2008 Dec 16;118(25):2748-53
pubmed: 19106399
Front Immunol. 2021 Dec 17;12:781280
pubmed: 34987509
Vaccine. 2019 Feb 8;37(7):956-964
pubmed: 30655174
Front Microbiol. 2018 Apr 26;9:783
pubmed: 29755431
Lancet Infect Dis. 2005 Nov;5(11):685-94
pubmed: 16253886
Vaccine. 2016 Jun 3;34(26):2953-2958
pubmed: 27032515
Biotechnol J. 2015 Sep;10(11):1689-706
pubmed: 26912077
PLoS One. 2013 Apr 08;8(4):e60969
pubmed: 23593359

Auteurs

Elena Palmieri (E)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Zoltán Kis (Z)

The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK.
Department of Chemical and Biological Engineering, The University of Sheffield, Mappin Street, Sheffield S1 3JD, UK.

James Ozanne (J)

The National Institute for Biological Standards and Control (NIBSC), South Mimms EN6 3QG, UK.

Roberta Di Benedetto (R)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Beatrice Ricchetti (B)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Luisa Massai (L)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Martina Carducci (M)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Davide Oldrini (D)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Gianmarco Gasperini (G)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Maria Grazia Aruta (MG)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Omar Rossi (O)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Cleo Kontoravdi (C)

The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK.

Nilay Shah (N)

The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK.

Fatme Mawas (F)

The National Institute for Biological Standards and Control (NIBSC), South Mimms EN6 3QG, UK.

Francesca Micoli (F)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Classifications MeSH